MSK Research Highlights, September 3, 2024

New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).

Blood Protein Levels and Birth Control Pills May Increase Blood Clot Risk in Female Astronauts

Article title: Albumin, oral contraceptives and venous thromboembolism risk in astronauts Authors: Sara R. Zwart, Serena M. Auñón-Chancellor, Martina Heer, M. Mark Melin, Scott M. Smith From the authors: “We report here evidence of an association between oral contraceptive use…